Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SZSE: 002603)
Health Care · Pharmaceuticals · CN
CN¥15.53
+1.17% today · -3.1% 1Y
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SZSE: 002603) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.87B and employs 11,343 people.
Over the last twelve months the share price has lost 3.1%, trading between 14.22 and 21.58.
Tweenvest scores Shijiazhuang Yiling Pharmaceutical Co., Ltd. across four factors: quality 69/100, value 65/100, growth 87/100. Its strongest factor is growth.
002603 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.87B
- Revenue (TTM)
- $1.16B
- P/E
- 18.87
- EPS
- 0.82
- Dividend yield
- —
- Beta (5Y)
- 0.41
- 52-week high
- CN¥21.58
- 52-week low
- CN¥14.22
- Avg volume (3M)
- —
- Shares outstanding
- 1.67B
- Employees
- 11,343
- Next earnings
- —
About Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
- ISIN
- CNE1000015S0
- Founded
- 1992
- Listed since
- Jul 28, 2011
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc.NasdaqGS: INDV | $4.23B | $35.70 | -0.36% |
| Yuhan CorporationKOSE: A000100 | $4.06B | ₩73,100.00 | -1.35% |
| J. B. Chemicals & Pharmaceuticals LimitedBSE: 506943 | $4.02B | Rs— | — |
| Zhejiang Huahai Pharmaceutical Co., Ltd.SHSE: 600521 | $3.88B | CN¥17.45 | +6.79% |
| Camurus AB (publ)OM: CAMX | $3.81B | Skr639.50 | -0.23% |
| Hypera S.A.BOVESPA: HYPE3 | $3.81B | R$26.93 | +0.86% |
| Caliway Biopharmaceuticals Co., Ltd.TWSE: 6919 | $3.77B | NT$77.50 | -3.00% |
| Hubei Jumpcan Pharmaceutical Co., Ltd.SHSE: 600566 | $3.67B | CN¥26.70 | +2.61% |
Figures last refreshed Oct 11, 2026.